Julia Coit

Statistics

Publications

Citations

488

H-Index

Active since

2016

Affiliations

Harvard University(Current)

EsSALUD

Harvard Global Health Institute

Brigham and Women's Hospital

Partners In Health

Julia Coit is an author at Harvard University specializing in tuberculosis control, mycobacterium tuberculosis infection, and tuberculosis diagnostic testing.

ORCID

Publications per year

2016–2023

Publications

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Gustavo E. Velásquez, Meredith B. Brooks, Julia Coit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 113 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

A positively selected FBN1 missense variant reduces height in Peruvian individuals

Samira Asgari, Yang Luo, Ali Akbari et al. · Nature · 2020 · 58 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Mycobacterium tuberculosis detection from oral swabs with Xpert MTB/RIF ULTRA: a pilot study

Annelies W. Mesman, Róger Calderón, Martín Soto et al. · BMC Research Notes · 2019 · 55 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis

Charles A. Peloquin, Gustavo E. Velásquez, Leonid Lecca et al. · Antimicrobial Agents and Chemotherapy · 2017 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

M. Milstein, Leonid Lecca, Charles A. Peloquin et al. · BMC Infectious Diseases · 2016 · 32 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

1–5 of 14